INS and Insulin resistance: Indeed, animal and cell studies have shown that SFAs, Palmitate, in particular, directly upregulates de-novo ceramide synthesis and immune signalling activation, possibly via activation of the TLR4, and indirectly compromises insulin signalling to promote insulin resistance [282,283].